A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, ...

Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult ...

Scientists Develop Scans That Light-Up Aggressive Cancer Tumors for Better Treatment Dec. 17, 2024 — Researchers have used a chemical compound to light up treatment-resistant cancers on imaging ...

a CD46-targeting antibody-drug conjugate (ADC) for the treatment of metastatic castration-resistant prostate cancer (mCRPC) that it licensed last year from Fortis Therapeutics. At this year's ASCO ...

Rapid molecular diagnostic technologies are highly effective lab tests that can detect genes of pathogens, and often drug resistant ... even breast cancer." The two-year treatment was long and ...

and fulfil its aim of €3 billion in peak sales for the drug. Nubeqa is already making headway in the market as a treatment for non-metastatic, castration resistant prostate cancer (nmCRPC), with ...

And even when they are not deadly, they can disrupt cancer treatment. But the frequency and extent of drug-resistant infections in cancer patients, and how they impact treatment, are less well ...

Led by scientists at the Laboratory of Biomedicine (Institut Curie/CNRS/Inserm) 2, this study is based on the remarkable properties of what are known as drug-tolerant ... of pancreatic cancer and ...

A 20-cent “wonder drug” may do more than manage blood ... exploring whether metformin could be used in treatment plans once colon cancer has already developed. “Metformin seems like it ...